By and Large, Thrombectomy in Large Core Is a Palpable Reality

Standard

By and Large, Thrombectomy in Large Core Is a Palpable Reality. / Haussen, Diogo C; Fiehler, Jens.

in: STROKE, Jahrgang 53, Nr. 8, 08.2022, S. 2709-2712.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungAndere (Vorworte u.ä.)Forschung

Harvard

APA

Vancouver

Bibtex

@article{ebdf6393364d423ba9a8f2c65ac90aeb,
title = "By and Large, Thrombectomy in Large Core Is a Palpable Reality",
abstract = "Our Japanese colleagues deserve much praise for finishing the first randomized clinical trial of thrombectomy in Alberta Stroke Program Early CT Score 3 to 5 patients showing an impressive therapy effect of thrombectomy. The predominant use of magnetic resonance imaging for patient selection, the low rate of alteplase therapy and its low dose limit direct comparisons with patients treated outside of Japan. Another limitation is the lack of benefit when using the traditional metric-modified Rankin Scale score 0-2. We consider the results of RESCUE-Japan LIMIT encouraging and a clear motivation to continue and complete other studies.",
keywords = "Brain Ischemia/drug therapy, Endovascular Procedures, Humans, Stroke/diagnostic imaging, Thrombectomy/methods, Tissue Plasminogen Activator/therapeutic use, Treatment Outcome",
author = "Haussen, {Diogo C} and Jens Fiehler",
year = "2022",
month = aug,
doi = "10.1161/STROKEAHA.122.039069",
language = "English",
volume = "53",
pages = "2709--2712",
journal = "STROKE",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

RIS

TY - JOUR

T1 - By and Large, Thrombectomy in Large Core Is a Palpable Reality

AU - Haussen, Diogo C

AU - Fiehler, Jens

PY - 2022/8

Y1 - 2022/8

N2 - Our Japanese colleagues deserve much praise for finishing the first randomized clinical trial of thrombectomy in Alberta Stroke Program Early CT Score 3 to 5 patients showing an impressive therapy effect of thrombectomy. The predominant use of magnetic resonance imaging for patient selection, the low rate of alteplase therapy and its low dose limit direct comparisons with patients treated outside of Japan. Another limitation is the lack of benefit when using the traditional metric-modified Rankin Scale score 0-2. We consider the results of RESCUE-Japan LIMIT encouraging and a clear motivation to continue and complete other studies.

AB - Our Japanese colleagues deserve much praise for finishing the first randomized clinical trial of thrombectomy in Alberta Stroke Program Early CT Score 3 to 5 patients showing an impressive therapy effect of thrombectomy. The predominant use of magnetic resonance imaging for patient selection, the low rate of alteplase therapy and its low dose limit direct comparisons with patients treated outside of Japan. Another limitation is the lack of benefit when using the traditional metric-modified Rankin Scale score 0-2. We consider the results of RESCUE-Japan LIMIT encouraging and a clear motivation to continue and complete other studies.

KW - Brain Ischemia/drug therapy

KW - Endovascular Procedures

KW - Humans

KW - Stroke/diagnostic imaging

KW - Thrombectomy/methods

KW - Tissue Plasminogen Activator/therapeutic use

KW - Treatment Outcome

U2 - 10.1161/STROKEAHA.122.039069

DO - 10.1161/STROKEAHA.122.039069

M3 - Other (editorial matter etc.)

C2 - 35861805

VL - 53

SP - 2709

EP - 2712

JO - STROKE

JF - STROKE

SN - 0039-2499

IS - 8

ER -